You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EC20

Showing 1 - 25 of 3,682
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Breast Cancer Trial in London (Tamoxifen Citrate 20Mg Tab, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen Citrate 20Mg Tab
  • Placebo
  • London, England, United Kingdom
    Queen Mary University of London
Jan 13, 2023

Non Small Cell Lung Cancer Trial (EC145, EC145 + Docetaxel, Docetaxel)

Completed
  • Non Small Cell Lung Cancer
  • (no location specified)
Mar 30, 2021

Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2023

Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

Terminated
Has Results
  • Small Cell Lung Cancer
  • ADI-PEG 20 (Arginine deiminase pegylated)
  • New York, New York
  • +7 more
Oct 3, 2022

Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines Trial in Chongqing (drug, diagnostic test,

Completed
  • Severe Acute Respiratory Syndrome-related Coronavirus
  • +4 more
  • Nifedipine 30 MG
  • +10 more
  • Chongqing, Chongqing, China
    Residential Address
Feb 1, 2023

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Adult Patients Who Initiate Systemic Treatment for Relapsed or

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Non-Interventional
  • Graz, Austria
  • +8 more
Sep 19, 2022

Health-related Quality of Life Tool for Cardiac Sarcoidosis

Recruiting
  • Cardiac Sarcoidosis
    • Cambridge, United Kingdom
    • +1 more
    Jan 26, 2022

    Adult Patients Who Initiate Systemic Treatment for

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • Non-Interventional
    • Graz, Austria
    • +8 more
    Sep 19, 2022

    Anthrax Trial in Lenexa (BW-1010: 50 µg - sprayer - IN, BW-1010: 50 µg - pipette - IN, BW-1010: 100 µg - sprayer - IN)

    Completed
    • Anthrax
    • BW-1010: 50 µg - sprayer - IN
    • +6 more
    • Lenexa, Kansas
      Johnson County Clin-Trial
    May 12, 2022

    Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

    Completed
    • Mesothelioma
    • ADI-PEG 20 plus Pem Cis
    • Placebo plus Pem Cis
    • Phoenix, Arizona
    • +44 more
    Sep 30, 2022

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Manchester, Greater Manchester, United Kingdom
    • +6 more
    Jan 5, 2023

    Investigate Adaptation and Evolution of Ovarian High-grade

    Recruiting
    • Ovarian Cancer
    • +6 more
      • Bristol, United Kingdom
      • +10 more
      Sep 8, 2022

      Lymphoma Trial in United Kingdom (biological, drug, radiation)

      Terminated
      • Lymphoma
      • rituximab
      • +5 more
      • Manchester, England, United Kingdom
      • +4 more
      Dec 16, 2021

      Adult Growth Hormone Deficiency Trial in Worldwide (somavaratan)

      Completed
      • Adult Growth Hormone Deficiency
      • Escondido, California
      • +17 more
      Jul 22, 2022

      Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

      Active, not recruiting
      • Muscle Invasive Bladder Cancer
      • Los Angeles, California
      • +26 more
      Oct 17, 2022

      Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

      Recruiting
      • Eye Diseases
      • +2 more
      • Pars plana vitrectomy
      • +3 more
      • Chelmsford, Essex, United Kingdom
      • +13 more
      Aug 2, 2022

      Multiple Myeloma Trial in United Kingdom (Pomalidomide, Dexamethasone, Cyclophosphamide)

      Active, not recruiting
      • Multiple Myeloma
      • Belfast, United Kingdom
      • +20 more
      May 24, 2022

      Deciphering AMD by Deep Phenotyping and Machine Learning-

      Recruiting
      • Age-related Macular Degeneration
        • Vienna, Austria
        • +11 more
        Sep 29, 2021

        Pleural Mesothelioma Malignant Advanced, Peritoneal Mesothelioma Malignant Advanced, Non-squamous Non-small Cell Lung Carcinoma

        Terminated
        • Pleural Mesothelioma Malignant Advanced
        • +6 more
        • ADI-PEG 20
        • Rochester, Minnesota
        • +3 more
        Sep 24, 2020

        Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer Trial in United Kingdom (zoledronic acid, quality-of-life

        Terminated
        • Breast Cancer
        • +4 more
        • zoledronic acid
        • quality-of-life assessment
        • Bournemouth, England, United Kingdom
        • +29 more
        May 23, 2022

        Waldenstrom Macroglobulinemia Trial in United Kingdom (Pembrolizumab, Rituximab)

        Recruiting
        • Waldenstrom Macroglobulinemia
        • Plymouth, Devon, United Kingdom
        • +7 more
        May 17, 2021

        Renal Cell Cancer Trial in Japan, United Kingdom, United States (Avelumab (MSB0010718C), Axitinib (AG-013736))

        Completed
        Has Results
        • Renal Cell Cancer
        • Avelumab (MSB0010718C)
        • Axitinib (AG-013736)
        • Scottsdale, Arizona
        • +20 more
        Dec 6, 2021